These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15686945)

  • 1. 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1.
    Wattanasin S; Kallen J; Myers S; Guo Q; Sabio M; Ehrhardt C; Albert R; Hommel U; Weckbecker G; Welzenbach K; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1217-20. PubMed ID: 15686945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,4-Diazepane-2-ones as novel inhibitors of LFA-1.
    Wattanasin S; Albert R; Ehrhardt C; Roche D; Sabio M; Hommel U; Welzenbach K; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2003 Feb; 13(3):499-502. PubMed ID: 12565959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
    Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
    Potin D; Launay M; Nicolai E; Fabreguette M; Malabre P; Caussade F; Besse D; Skala S; Stetsko DK; Todderud G; Beno BR; Cheney DL; Chang CJ; Sheriff S; Hollenbaugh DL; Barrish JC; Iwanowicz EJ; Suchard SJ; Dhar TG
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1161-4. PubMed ID: 15686933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-substituted heterocycles as isosteres of trans-cinnamides: design and synthesis of heterocyclic biaryl sulfides as potent antagonists of LFA-1/ICAM-1 binding.
    Wang GT; Wang S; Gentles R; Sowin T; Leitza S; Reilly EB; von Geldern TW
    Bioorg Med Chem Lett; 2005 Jan; 15(1):195-201. PubMed ID: 15582439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
    Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists.
    Link JT; Sorensen B; Liu G; Pei Z; Reilly EB; Leitza S; Okasinski G
    Bioorg Med Chem Lett; 2001 Apr; 11(8):973-6. PubMed ID: 11327603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locking a leukocyte integrin with statins.
    Frenette PS
    N Engl J Med; 2001 Nov; 345(19):1419-21. PubMed ID: 11794177
    [No Abstract]   [Full Text] [Related]  

  • 9. Virtual screening leads to the discovery of an effective antagonist of lymphocyte function-associated antigen-1.
    Shoda M; Harada T; Yano K; Stahura FL; Himeno T; Shiojiri S; Kogami Y; Kouji H; Bajorath J
    ChemMedChem; 2007 Apr; 2(4):515-21. PubMed ID: 17340656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein--protein interaction.
    Last-Barney K; Davidson W; Cardozo M; Frye LL; Grygon CA; Hopkins JL; Jeanfavre DD; Pav S; Qian C; Stevenson JM; Tong L; Zindell R; Kelly TA
    J Am Chem Soc; 2001 Jun; 123(24):5643-50. PubMed ID: 11403595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety.
    Burdick DJ; Marsters JC; Aliagas-Martin I; Stanley M; Beresini M; Clark K; McDowell RS; Gadek TR
    Bioorg Med Chem Lett; 2004 May; 14(9):2055-9. PubMed ID: 15080978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramethylpyrazine inhibits phytohemagglutinin-induced upregulation of ICAM-1 and LFA-1 mediated leukocyte adhesion.
    Zhao H; Zhu C; Li X; Dong X; Zhuang F; Wang X; Stoltz JF
    Clin Hemorheol Microcirc; 2000; 23(2-4):145-51. PubMed ID: 11321434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors.
    Beaulieu F; Ouellet C; Ruediger EH; Belema M; Qiu Y; Yang X; Banville J; Burke JR; Gregor KR; MacMaster JF; Martel A; McIntyre KW; Pattoli MA; Zusi FC; Vyas D
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1233-7. PubMed ID: 17197177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of molecular binding events and cellular compliance to the modulation of leukocyte adhesion.
    Wojcikiewicz EP; Zhang X; Chen A; Moy VT
    J Cell Sci; 2003 Jun; 116(Pt 12):2531-9. PubMed ID: 12734401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.
    Keating SM; Clark KR; Stefanich LD; Arellano F; Edwards CP; Bodary SC; Spencer SA; Gadek TR; Marsters JC; Beresini MH
    Protein Sci; 2006 Feb; 15(2):290-303. PubMed ID: 16384997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of encoded library technology (ELT) to a protein-protein interaction target: discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists.
    Kollmann CS; Bai X; Tsai CH; Yang H; Lind KE; Skinner SR; Zhu Z; Israel DI; Cuozzo JW; Morgan BA; Yuki K; Xie C; Springer TA; Shimaoka M; Evindar G
    Bioorg Med Chem; 2014 Apr; 22(7):2353-65. PubMed ID: 24593905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antibacterial class: a series of tetracyclic derivatives.
    Hinman MM; Rosenberg TA; Balli D; Black-Schaefer C; Chovan LE; Kalvin D; Merta PJ; Nilius AM; Pratt SD; Soni NB; Wagenaar FL; Weitzberg M; Wagner R; Beutel BA
    J Med Chem; 2006 Aug; 49(16):4842-56. PubMed ID: 16884296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castanospermine, an oligosaccharide processing inhibitor, reduces both lymphocyte-endothelial cell binding and LFA-1alpha membrane expression.
    Clark DA; Hibberd AD; Trevillian PR; Cowden WB
    Transplant Proc; 2001; 33(1-2):522. PubMed ID: 11266936
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-free ligand-binding assays for integrin LFA-1.
    Yuki K
    Methods Mol Biol; 2012; 757():73-8. PubMed ID: 21909907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.
    Weitz-Schmidt G; Welzenbach K; Brinkmann V; Kamata T; Kallen J; Bruns C; Cottens S; Takada Y; Hommel U
    Nat Med; 2001 Jun; 7(6):687-92. PubMed ID: 11385505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.